Lazard Asset Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Lazard Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $115,090 - $120,918	-794 Reduced 63.88%	449 $67,000
Q2 2022 Aug 09, 2022	BUY	$83.14 - $145.99 $30,595 - $53,724	368 Added 42.06%	1,243 $181,000
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $440 - $571	-4 Reduced 0.46%	875 $103,000
Q4 2021 Feb 09, 2022	SELL	$99.73 - $148.48 $809,508 - $1.21 Million	-8,117 Reduced 90.23%	879 $121,000
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $802,068 - $1.13 Million	8,114 Added 919.95%	8,996 $1.25 Million
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $51,045 - $81,495	776 Added 732.08%	882 $85,000
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $32,931 - $47,159	-514 Reduced 82.9%	106 $7,000
Q4 2020 Feb 11, 2021	BUY	$65.07 - $98.24 $40,343 - $60,908	620 New	620 $53,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.